Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development-Reference-Cited by-同舟云学术

Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development

Published:2010-10 Issue:5 Volume:32 Page:615-623
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Norris Ross L,Martin Jennifer H,Thompson Erin,Ray John E,Fullinfaw Robert O,Joyce David,Barras Michael,Jones Graham R,Morris Raymond G

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference19 articles.

1. More doctors, but not enough: Australian medical workforce supply 2001-2012.;Joyce;Med J Aust,2006

2. Medication safety in acute care in Australia: where are we now? Part I: a review of the extent and causes of medication problems 2002-2008.;Roughead;Aust NZ Health Policy,2009

3. Adverse drug events and medication errors in Australia.;Runciman;Int J Qual Health Care,2003

4. Medication use leading to emergency department visits for adverse drug events in older adults.;Budnitz;Ann Intern Med,2007

5. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.;van Lent-Evers N, Mathot;Ther Drug Monit,1999

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Italian external quality assessment program for Cystic Fibrosis sweat chloride test: CFTR modulators and the impact of a new sweat test report form;Practical Laboratory Medicine;2024-05

2. Impact of model-informed precision dosing in adults receiving vancomycin via continuous infusion: a randomized, controlled clinical trial;Trials;2024-02-16

3. The Italian External Quality Assessment Program for Cystic Fibrosis Sweat Chloride Test: Cftr Modulators and the Impact of a New Sweat Test Report Form;2024

4. The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting;Journal of Antimicrobial Chemotherapy;2023-07-19

5. Optimization of Antimicrobial Stewardship Programs Using Therapeutic Drug Monitoring and Pharmacokinetics–Pharmacodynamics Protocols: A Cost-Benefit Review;Therapeutic Drug Monitoring;2023-01-02